NATR President Kevin Herbert Sells $41K of Stock
An executive at Nature's Sunshine Products recently unloaded shares, adding to a series of insider sales over the summer.
Reviewed by automated data checks against the source filing. How we make and check alerts
Kevin Herbert, EVP & President, North America at Nature's Sunshine Products, Inc. ($NATR), sold 2,000 shares at an average price of $20.68, worth about $41,364, on June 12, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $NATR is down 0.5% after 1 week, up 5.2% after 1 month and down 38.4% to date (from the $20.51 close on Jun 12, 2026).
Key Points
- Kevin Herbert, EVP and President of North America at Nature's Sunshine Products, Inc. (NATR), sold 2,000 shares of stock on June 12, 2026, at an average price of $20.68 for a total value of $41,364.
- The stock trades near $20.04, sitting below its 200-day moving average of $21.90 while staying profitable with a P/E ratio of 13.02.
- Wall Street firms remain positive on the health and wellness company, with DA Davidson and Canaccord Genuity maintaining buy ratings over the summer.
Get $NATR trade alerts by text
We text you when insiders, Congress or big funds trade $NATR. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Nature's Sunshine Products, Inc. alert may contain errors. Disclosures
Insider Buying and Selling at Nature's Sunshine Products, Inc.
Kevin Herbert, who serves as the Executive Vice President and President of North America for Nature's Sunshine Products, Inc. (NasdaqCM: NATR), unloaded 2,000 shares of company stock on June 12, 2026. The transaction took place at an average price of $20.68, bringing the total value of the sale to $41,364. This move follows a similar transaction earlier in the summer, establishing a clear pattern of insider activity for this corporate officer.
Looking closer at the timeline, this transaction joins an earlier sale recorded on June 26, 2026, when Herbert parted with 1,976 shares at an average price of $21.02, totaling $41,535.52. Neither of these June transactions was executed under a pre-arranged Rule 10b5-1 trading plan. Insider sales are common for executives managing their personal wealth or stock compensation packages and do not inherently signal a negative outlook from company leadership.
Nature's Sunshine Stock Trades Near Moving Averages
Shares of Nature's Sunshine Products recently changed hands around $20.04. The company maintains a market capitalization of about $229.09 million and a trailing price-to-earnings ratio of 13.02, alongside a forward P/E ratio of 10.59. The equity moves within a 52-week band stretching from a low of $12.80 to a high of $28.14. Its 50-day moving average rests at $16.67, while the longer 200-day moving average sits higher at $21.90.
Analysts Set New Price Targets
Financial institutions following the health and wellness provider have kept favorable outlooks on the equity through the summer months. On August 10, 2026, DA Davidson maintained its buy rating on the stock while adjusting its price target from $33.00 down to $25.00. Shortly before that, Canaccord Genuity also kept a buy rating in place on July 30, 2026, moving its target from $37.00 to $36.00. Overall, the company carries a consensus mean target price of $30.50 based on two analyst opinions.
Understanding Nature's Sunshine Products
Headquartered in Lehi, Utah, Nature's Sunshine Products operates as a natural health and wellness enterprise that manufactures and distributes nutritional and personal care items across global markets. The firm offers a wide selection of general health goods, immune support items, cardiovascular formulations, digestive aids, and weight management products. Distribution relies on a network of independent consultants who connect customers with the company's branded merchandise.
Upcoming Financial Reporting Schedule
Market participants are looking forward to the company's next financial results release, which is scheduled for November 9, 2026. Investors will monitor upcoming reports to gauge revenue trends and profit margins following a fiscal period that generated $492.02 million in revenue and a net margin of 3.68% over the trailing year.
Source: Kevin Herbert's Form 4 filing on $NATR (Jun 12, 2026). Find the original filing: NATR Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts
